A Chinese biotech that became popular by co-developing an anti-Covid drug has filed for a Hong Kong stock market listing.
As Covid Drug Cash Dwindles, Vigonvita Targets New Remedies
Where Today's News Shapes Tomorrow
March 14, 2026
Headlines
